The role of tumour necrosis factor-alpha in the pathogenesis of complicated falciparum malaria.
Plasmodium falciparum malaria is the most important parasitic infection of humans and is one of the most serious health problems facing the inhabitants of developing countries. It is responsible for about 2 million deaths every year. To date there is no specific treatment for the disease apart from anti-malarials. The declining sensitivity to these drugs is a serious therapeutic problem, while no safe and effective vaccine is likely to be available for general use in the near future. There is now abundant laboratory and clinical evidence to suggest that tumour necrosis factor-alpha (TNF-alpha) plays a major role in the pathogenesis of complicated falciparum malaria. Modulation of TNF-alpha response in combination with the current anti-malarial drugs, may represent a novel approach to the treatment of the serious complications associated with the disease.
Odeh
M
M
Department of Internal Medicine, Bnai Zion Medical Center, Haifa, Israel.
D000140:Acidosis, Lactic / Q000150:complications / Q000378:metabolism / Q000503:physiopathology; D000740:Anemia / Q000150:complications / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D007003:Hypoglycemia / Q000150:complications / Q000378:metabolism / Q000503:physiopathology; D016779:Malaria, Cerebral / Q000150:complications / Q000378:metabolism / Q000503:physiopathology; D016778:Malaria, Falciparum / Q000188:drug therapy / Q000378:metabolism* / Q000503:physiopathology*; D011654:Pulmonary Edema / Q000150:complications / Q000378:metabolism / Q000503:physiopathology; D051437:Renal Insufficiency / Q000150:complications / Q000378:metabolism / Q000503:physiopathology; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
D014409:Tumor Necrosis Factor-alpha